Hexagon Capital Partners’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15	Closed	-$204	–	501
2025 Q1	$204	Buy	15 +3	+25%	+$41	﹤0.01%	1755
2024 Q4	$245	Buy	+12	New	+$245	﹤0.01%	1753